The Endocrine Disruptor Page HomeSitemap
 

Chemical Safety Office
Evaluation and Licensing Division
Pharmaceutical and Food Safety Bureau
Ministry of Health, Labor and Welfare

Japanese

Last updated date: March 30, 2015
 

Home

 Advisory Committee

   Actions

     Scheme

     Overview

FAQs

Bisphenol A

Reports, etc.

Related reports

Links

Contact


 
Reports

Advisory Committee on Health Effects of Endocrine Disruptors
The Supplement II to the Intermediary Report
1.3.2

 

contents  Detailed contents  << prev  next >>

 

This means that it is difficult to develop a test method with general applicability to hormone-like substances.

(1) Overview of the low-dose issue
The low-dose issue is a complex of several topics closely related one another. Examples are existence of threshold values and additive or multiplicative effects, adequacy of extrapolation from high dose data to low dose region, and linearity of the dose-active relationship. Some of them are reviewed in the following.
Existence (or non-existence) of a threshold value can be demonstrated biostatistically assuming a model of the dose-effect relationship. Earl Gray of EPA found that various feminization indexes of antiandrogens show similar logistic curves or S curves, which approach the base line levels insofar as observed12,13. Experimental systems independent of homeostasis14 are known to reveal effects at very low doses even in vivo15,16. Since the living organism detects a low dose of a hormone-like substance and reacts to it, rather than neglects it, this type of in vivo studies with particular treatment, though indicative of low-dose responses of organisms, does not provide information on deleterious effects of substances.
 

 
Palanza P, Howdeshell KL, Parmigiani S, vom Saal FS.: Exposure to a low dose of biosphenol A during fetal life or in adulthood alters maternal behavior in mice. Environ Health Perspect 110,Suppl.3:415-422,2002. / Schonfelder G, Flick B, Mayr E, Talsness C, Paul M, Chahoud I.: In utero exposre to low doses of bisphenol A lead to long-term deleterious effects in the vagina. Neoplasia 4:98-102, 2002. / Schonfelder G,Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I.: Parent bisphenol A accumulation in the humanmaternal-fetal-placental unit. Environ Health Perspect 110: A703-707, 2002. / Tinwell H, Haseman J,Lefevre PA, Wallis N, Ashby J.: Normal sexual development of two strains of rat exposed in utero to low doses of bisphenol A.: Toxicol Sci 68:339-348, 2002./ Wetherill YB, Petre CE, Monk KR, Puga A,Knudsen KE.: The xenoestrogen bisphenol A induces innapriopriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells. Mol Cancer Ther 1:515-524, 2002. / Ashby J.: Testing for endocrine disruption post-EDSTAC: extrapolation of low dose rodent effects to humans. Toxicol Lett 120:233-242, 2001 ./ Markey CM, Luque EH, Munoz De Toro M, Sonnenschein C, Soto AM.] In utero exposre to bisphenol A alters the development and tissue organization of the mouse mammary gland. Bio Reprod 65: 1215-1223, 2001. / Markey CM, Michaelson CL, Veson EC, Sonnenschein C, Soto AM.:The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A.Environ Health Perspect 109: 55-60, 2001. / Gupta C.: Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc Soc Exptl Biol Med. 224: 61-68, 2000. / Elswick BA, Welsch F, Janszen DB.: Effect of different sampling designs on outcome of endocrine disruptor studies. Reprod Toxicol 14:359-367, 2000./ Oehlmann J, Schulte-Oehlmann U, Tillmann M,Markert B.: Effect of endocrine disruptors on prosobranch snail (Mollusca: Gastropoda) in the laboratory.
Part I: Bisphenol A and octylphenol as xeno-estrogen. Ecotoxicol 9: 383-397, 2000. / Tinwell H, Joiner R,Pate I, Soames A, Foster J, Ashby J.: Uterotrophic activity of bisphenol A in the immature mouse. Regul Toxicol Pharmacol 32:118-126, 2000. / Howdeshell KL, Hotchikiss AK, Thayer KA, Vandenbergh JG,vom Saal FS.: Environmental toxins: Exposure to bisphenol A advances puberty. Nature 401: 763-764,1999.
12 Gray LE Jr, Ostby J, Monosson E, Kelce WR.: Environmental antiandrogens: Low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicol Ind Health 15(1-2): 48-64, 1999.
13 Gray LE, Ostby J, Furr J, Wolf CJ, Lambright C, Parks L, Veeramachaneni DN, Wilson V, Price M,Hotchkiss A, Orlando E, Guillette L: Effcet of environmental antiandrogens on reproductive development in expereimental animals. Hum Reprod Update 7(3): 248-264, 2001.
14 E.g. the uterotrophic bioassay.
15 Kanno J, Onyon L, Haseman J, Fenner-Crisp P, Ashby J, Owens W: Environ Health Perspect 109(8):785-794, 2001.
16 Considering the fact that the probability of ligand-receptor association is naturally low at sufficiently low doses, "practical" threshold values for carcinogens are recently recognized by some researchers. The same possibly applies to endocrine disruptors as well.

contents  Detailed contents  << prev  next >>

 

 

About links, copyright, etc. Privacy policy

(C) 2005, 2016 Ministry of Health, Labour and Welfare, All Rights Reserved.